• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tau蛋白和淀粉样蛋白负荷对阿尔茨海默病葡萄糖代谢的影响。

Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease.

作者信息

Bischof Gérard N, Jessen Frank, Fliessbach Klaus, Dronse Julian, Hammes Jochen, Neumaier Bernd, Onur Oezguer, Fink Gereon R, Kukolja Juraj, Drzezga Alexander, van Eimeren Thilo

机构信息

Multimodal Neuroimaging Group Department of Nuclear Medicine University Hospital Cologne Cologne Germany; Cognitive Neuroscience Institute of Neuroscience and Medicine (INM-3)Research Center Jülich Jülich Germany.

German Center for Neurodegenerative Diseases (DZNE) Bonn Germany; Department of Psychiatry University Hospital Cologne Cologne Germany.

出版信息

Ann Clin Transl Neurol. 2016 Oct 20;3(12):934-939. doi: 10.1002/acn3.339. eCollection 2016 Dec.

DOI:10.1002/acn3.339
PMID:28097205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5224823/
Abstract

In a multimodal PET imaging approach, we determined the differential contribution of neurofibrillary tangles (measured with [F]AV-1451) and beta-amyloid burden (measured with [C]PiB) on degree of neurodegeneration (i.e., glucose metabolism measured with [F]FDG-PET) in patients with Alzheimer's disease. Across brain regions, we observed an interactive effect of beta-amyloid burden and tau deposition on glucose metabolism which was most pronounced in the parietal lobe. Elevated beta-amyloid burden was associated with a stronger influence of tau accumulation on glucose metabolism. Our data provide the first in vivo insights into the differential contribution of A and tau to neurodegeneration in Alzheimer's disease.

摘要

在一种多模态PET成像方法中,我们确定了神经纤维缠结(用[F]AV-1451测量)和β-淀粉样蛋白负荷(用[C]PiB测量)对阿尔茨海默病患者神经退行性变程度(即通过[F]FDG-PET测量的葡萄糖代谢)的不同贡献。在整个脑区,我们观察到β-淀粉样蛋白负荷和tau沉积对葡萄糖代谢的交互作用,这在顶叶最为明显。β-淀粉样蛋白负荷升高与tau积累对葡萄糖代谢的更强影响相关。我们的数据首次提供了关于A和tau对阿尔茨海默病神经退行性变的不同贡献的体内见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df21/5224823/a16f8b885c21/ACN3-3-934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df21/5224823/6c9036741712/ACN3-3-934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df21/5224823/a16f8b885c21/ACN3-3-934-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df21/5224823/6c9036741712/ACN3-3-934-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df21/5224823/a16f8b885c21/ACN3-3-934-g002.jpg

相似文献

1
Impact of tau and amyloid burden on glucose metabolism in Alzheimer's disease.tau蛋白和淀粉样蛋白负荷对阿尔茨海默病葡萄糖代谢的影响。
Ann Clin Transl Neurol. 2016 Oct 20;3(12):934-939. doi: 10.1002/acn3.339. eCollection 2016 Dec.
2
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.采用多模态范式,利用THK5317正电子发射断层扫描(PET)对阿尔茨海默病体内的tau病理进行成像。
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1686-99. doi: 10.1007/s00259-016-3363-z. Epub 2016 Mar 21.
3
Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.基于体素的阿尔茨海默病 PET 成像三探针分析:PIB、FDDNP 和 FDG。
Neuroimage. 2010 Aug 15;52(2):488-96. doi: 10.1016/j.neuroimage.2010.04.013. Epub 2010 Apr 10.
4
Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.年龄、β-淀粉样蛋白沉积和葡萄糖代谢之间的动态关系与阿尔茨海默病的区域易损性相关。
Brain. 2016 Aug;139(Pt 8):2275-89. doi: 10.1093/brain/aww108. Epub 2016 May 13.
5
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.氟替卡匹尔PET tau蛋白结合与淀粉样蛋白负荷、临床诊断、年龄和认知之间的关系。
Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.
6
FDG-PET and amyloid-PET imaging: the diverging paths.氟代脱氧葡萄糖正电子发射断层扫描(FDG-PET)与淀粉样蛋白正电子发射断层扫描(amyloid-PET)成像:分道扬镳之路。
Curr Opin Neurol. 2014 Aug;27(4):405-13. doi: 10.1097/WCO.0000000000000109.
7
PET of brain amyloid and tau in mild cognitive impairment.轻度认知障碍患者脑淀粉样蛋白和tau蛋白的正电子发射断层显像(PET)
N Engl J Med. 2006 Dec 21;355(25):2652-63. doi: 10.1056/NEJMoa054625.
8
Functional correlates of t-Tau, p-Tau and Aβ₁₋₄₂ amyloid cerebrospinal fluid levels in Alzheimer's disease: a ¹⁸F-FDG PET/CT study.阿尔茨海默病中总tau蛋白、磷酸化tau蛋白和Aβ₁₋₄₂淀粉样蛋白脑脊液水平的功能相关性:一项¹⁸F-FDG PET/CT研究
Nucl Med Commun. 2015 May;36(5):461-8. doi: 10.1097/MNM.0000000000000272.
9
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.阿尔茨海默病患者淀粉样蛋白沉积的两年随访
Brain. 2006 Nov;129(Pt 11):2856-66. doi: 10.1093/brain/awl178. Epub 2006 Jul 19.
10
Regional tau deposition measured by [F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer's disease.通过[F]THK5317正电子发射断层扫描测量的区域tau沉积与阿尔茨海默病中通过葡萄糖代谢的认知相关。
Alzheimers Res Ther. 2016 Sep 29;8(1):38. doi: 10.1186/s13195-016-0204-z.

引用本文的文献

1
Results of the first-in-human, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study of BIIB113 in healthy volunteers.BIIB113在健康志愿者中进行的首次人体随机双盲安慰剂对照单剂量及多剂量递增研究结果。
J Prev Alzheimers Dis. 2025 Sep;12(8):100302. doi: 10.1016/j.tjpad.2025.100302. Epub 2025 Jul 21.
2
Tau-related reduction of glucose metabolism in mild cognitive impairment occurs independently of APOE ε4 genotype and is influenced by Aβ.轻度认知障碍中与tau蛋白相关的葡萄糖代谢降低独立于APOE ε4基因型发生,并受Aβ影响。
Alzheimers Dement. 2025 Feb;21(2):e14625. doi: 10.1002/alz.14625.
3

本文引用的文献

1
Regional brain hypometabolism is unrelated to regional amyloid plaque burden.局部脑代谢减退与局部淀粉样斑块负荷无关。
Brain. 2015 Dec;138(Pt 12):3734-46. doi: 10.1093/brain/awv278. Epub 2015 Sep 29.
2
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.在尸检脑组织上验证新型tau正电子发射断层显像示踪剂[F-18]-AV-1451(T807)
Ann Neurol. 2015 Nov;78(5):787-800. doi: 10.1002/ana.24517. Epub 2015 Sep 25.
3
Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
Cognitive variation reflects amyloid, tau, and neurodegenerative biomarkers in Alzheimer's disease.
认知变化反映了阿尔茨海默病中的淀粉样蛋白、tau蛋白和神经退行性生物标志物。
Geroscience. 2025 Jan 28. doi: 10.1007/s11357-025-01541-9.
4
Cortical Tau Aggregation Patterns Associated With Apraxia in Patients With Alzheimer Disease.阿尔茨海默病患者中与失用症相关的皮质tau聚集模式
Neurology. 2024 Dec 24;103(12):e210062. doi: 10.1212/WNL.0000000000210062. Epub 2024 Dec 3.
5
Progressive Supranuclear Palsy: Subcortical Tau Depositions Are Associated with Cortical Perfusion in Frontal and Limbic Regions.进行性核上性麻痹:皮质下 tau 沉积与额极和边缘区域的皮质灌注相关。
J Parkinsons Dis. 2024;14(6):1271-1276. doi: 10.3233/JPD-240210.
6
Characterization of tau propagation pattern and cascading hypometabolism from functional connectivity in Alzheimer's disease.阿尔茨海默病中 tau 传播模式和级联低代谢的功能连接特征。
Hum Brain Mapp. 2024 May;45(7):e26689. doi: 10.1002/hbm.26689.
7
Neuropsychological differential diagnosis of Alzheimer's disease and vascular dementia: a systematic review with meta-regressions.阿尔茨海默病与血管性痴呆的神经心理学鉴别诊断:一项包含元回归分析的系统评价
Front Aging Neurosci. 2023 Nov 6;15:1267434. doi: 10.3389/fnagi.2023.1267434. eCollection 2023.
8
[F]-FDG uptake in brain slices prepared from an aged mouse model of Alzheimer's disease using a dynamic autoradiography technique.使用动态放射自显影技术在阿尔茨海默病老年小鼠模型的脑片中检测[F]-FDG 摄取。
Ann Nucl Med. 2024 Feb;38(2):120-130. doi: 10.1007/s12149-023-01879-0. Epub 2023 Nov 3.
9
Synthesizing images of tau pathology from cross-modal neuroimaging using deep learning.利用深度学习从跨模态神经影像学合成 tau 病理学图像。
Brain. 2024 Mar 1;147(3):980-995. doi: 10.1093/brain/awad346.
10
FDG-PET markers of heterogeneity and different risk of progression in amnestic MCI.遗忘型轻度认知障碍(amnestic MCI)中异质性和不同进展风险的 FDG-PET 标志物。
Alzheimers Dement. 2024 Jan;20(1):159-172. doi: 10.1002/alz.13385. Epub 2023 Jul 28.
淀粉样蛋白加速了早期阿尔茨海默病模型中的 tau 传播和毒性。
Acta Neuropathol Commun. 2015 Mar 24;3:14. doi: 10.1186/s40478-015-0199-x.
4
Prefrontal hypometabolism in Alzheimer disease is related to longitudinal amyloid accumulation in remote brain regions.阿尔茨海默病中的前额叶低代谢与远隔脑区的淀粉样蛋白纵向积累有关。
J Nucl Med. 2015 Mar;56(3):399-404. doi: 10.2967/jnumed.114.149302. Epub 2015 Feb 12.
5
Spreading of pathology in neurodegenerative diseases: a focus on human studies.神经退行性疾病中病理变化的传播:聚焦于人体研究。
Nat Rev Neurosci. 2015 Feb;16(2):109-20. doi: 10.1038/nrn3887. Epub 2015 Jan 15.
6
Primary age-related tauopathy (PART): a common pathology associated with human aging.原发性年龄相关性tau蛋白病(PART):一种与人类衰老相关的常见病理状态。
Acta Neuropathol. 2014 Dec;128(6):755-66. doi: 10.1007/s00401-014-1349-0. Epub 2014 Oct 28.
7
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia.一种用于痴呆症统计参数映射中空间归一化的标准化[18F]-氟代脱氧葡萄糖正电子发射断层显像模板。
Neuroinformatics. 2014 Oct;12(4):575-93. doi: 10.1007/s12021-014-9235-4.
8
Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.淀粉样蛋白-β 和 tau:阿尔茨海默病发病机制中的扳机和子弹。
JAMA Neurol. 2014 Apr;71(4):505-8. doi: 10.1001/jamaneurol.2013.5847.
9
Amyloid-β oligomerization in Alzheimer dementia versus high-pathology controls.阿尔茨海默病与高病理对照中的淀粉样β寡聚化。
Ann Neurol. 2013 Jan;73(1):104-19. doi: 10.1002/ana.23748. Epub 2012 Dec 7.
10
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.阿尔茨海默病病理过程的阶段:年龄类别为 1 至 100 岁。
J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379.